§ 02.2 Regulatory
Regulatory Compliance
Submissions, remediation, and EU/US regulatory strategy — built around the realities of inspections and post-market obligations.
We help life-sciences companies navigate the practical side of regulation: preparing submissions that stand up to scrutiny, remediating FDA 483 observations and Warning Letters, and building EU technical documentation that meets MDR requirements. Our work is grounded in what actually happens during inspections — not just what the guidance says.
§ 02.2.A What we deliver
Specific engagements in Regulatory.
- 01 Regulatory Submissions
- 02 FDA QSub
- 03 FDA 483 / Warning Letters Remediations
- 04 EU Technical Documentation / Clinical Evaluation Plan (CEP) / Clinical Evaluation Report (CER)
- 05 Production / Environments